| review article | Q7318358 |
| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/J.1748-720X.2000.TB00686.X |
| P698 | PubMed publication ID | 11317427 |
| P2093 | author name string | C Weijer | |
| P2860 | cites work | Placebo-controlled trials in schizophrenia: are they ethical? Are they necessary? | Q53555561 |
| Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design | Q24569560 | ||
| Placebo orthodoxy in clinical research. I: Empirical and methodological myths | Q28305894 | ||
| The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews | Q29619407 | ||
| Ethics. Protecting communities in biomedical research. | Q33916317 | ||
| Equipoise and the ethics of clinical research | Q34050273 | ||
| Induced Hearing Deficit Generates Experimental Paranoia | Q50600785 | ||
| Research involving the vulnerable sick. | Q51962647 | ||
| Protecting communities in research: current guidelines and limits of extrapolation. | Q53538422 | ||
| P433 | issue | 4 | |
| P921 | main subject | ethical analysis | Q98139384 |
| research ethics | Q1132684 | ||
| P304 | page(s) | 344-361 | |
| P577 | publication date | 2000-01-01 | |
| P1433 | published in | Journal of Law, Medicine, and Ethics | Q15760852 |
| P1476 | title | The ethical analysis of risk | |
| P478 | volume | 28 |
| Q46371305 | A Defense of The-Risks-of-Daily-Life |
| Q34400859 | A comparison of symptom provocation procedures in psychiatry and other areas of medicine: implications for their ethical use in research |
| Q34496188 | Addressing the ethical challenges of clinical trials that involve patients with dementia |
| Q38082801 | An ethical analysis of proxy and waiver of consent in critical care research |
| Q36944964 | Are risks and benefits of oncological research protocols both incommensurable and incompensable? |
| Q37005071 | Assessing research risks systematically: the net risks test |
| Q35102974 | Benefits and burdens of placebos in psychiatric research |
| Q34576574 | Benefits, risks and ethical considerations in translation of stem cell research to clinical applications in Parkinson's disease |
| Q24806039 | Choosing a control intervention for a randomised clinical trial |
| Q45073020 | Clarifying the concept of the "Social" in risk assessments for human subjects research |
| Q48418842 | Clinical equipoise and risk-benefit assessment |
| Q36505148 | Concept paper: a virtual centralized IRB system |
| Q35105887 | Conducting Research That Involves Subjects at the End of Life Who Are Unable to Give Consent |
| Q36749688 | Consent and assent to participate in research from people with dementia |
| Q37644176 | Considerations and costs of disclosing study findings to research participants |
| Q40235207 | Considering Tangible Benefit for Interdependent Donors: Extending a Risk-Benefit Framework in Donor Selection. |
| Q38242596 | Deliberate Microbial Infection Research Reveals Limitations to Current Safety Protections of Healthy Human Subjects |
| Q36682458 | Disease-modifying trials in Alzheimer's disease: a European task force consensus |
| Q51783699 | Dissociations in the meaning of risk between health-care professionals and individuals with spinal cord injury. |
| Q35427837 | Eliminating the daily life risks standard from the definition of minimal risk |
| Q36276557 | Employment of substandard antiemetic prophylaxis in recent trials of chemotherapy-induced nausea and vomiting |
| Q33284467 | Enrolling adolescents in HIV vaccine trials: reflections on legal complexities from South Africa |
| Q46797749 | Equipoise in the enhanced supression of the platelet IIb/IIIa receptor with integrilin trial (ESPRIT): a critical appraisal |
| Q44389046 | Equipoise: asking the right questions for clinical trial design |
| Q40156980 | Ethical assessment of pediatric research protocols |
| Q38874665 | Ethical considerations and challenges in first-in-human research |
| Q36806611 | Ethical considerations for the conduct of antidementia trials in Canada |
| Q36948309 | Ethical issues in adolescent and parent informed consent for pediatric asthma research participation |
| Q56783697 | Ethical issues in health research in children |
| Q36560381 | Ethics and research in critical care |
| Q37872040 | European legislation impedes critical care research and fails to protect patients' rights |
| Q38613705 | Health care needs assessment among adolescents in correctional institutions in Zambia: an ethical analysis. |
| Q53446340 | I need a placebo like I need a hole in the head. |
| Q81672843 | Increasing the participation of children in clinical research |
| Q24807396 | International variation in ethics committee requirements: comparisons across five Westernised nations |
| Q37922803 | Justice, fairness, and membership in a class: conceptual confusions and moral puzzles in the regulation of human subjects research |
| Q94324856 | Les enjuex éthiques entourant la recherche en santé sur les enfants |
| Q35650573 | Minimal risk in research involving pregnant women and fetuses |
| Q46572565 | Neurosurgical Patients as Human Research Subjects: Ethical Considerations in Intracranial Electrophysiology Research |
| Q33992275 | No child left behind: Enrolling children and adults simultaneously in critical care randomized trials |
| Q58064570 | Pharmacogenomics and the challenge to privacy |
| Q53414315 | Placebos that harm: sham surgery controls in clinical trials. |
| Q35616213 | Protecting subjects with decisional impairment in research: the need for a multifaceted approach |
| Q35574019 | Protecting vulnerable research subjects in critical care trials: enhancing the informed consent process and recommendations for safeguards |
| Q44450089 | Randomization should be disclosed to potential research subjects. |
| Q53595196 | Recommendations in relation to the EU clinical trials directive and medical research involving incapacitated adults. |
| Q37005015 | Refuting the net risks test: a response to Wendler and Miller's "Assessing research risks systematically". |
| Q38069234 | Regenerative medicine interventions for orthopedic disorders: ethical issues in the translation into patients |
| Q37687469 | Research biopsies in phase I studies: views and perspectives of participants and investigators |
| Q34871708 | Research ethics committees and public dissemination of clinical trial results |
| Q36296531 | Research in critically ill patients: standards of informed consent |
| Q36582005 | Review of a mock research protocol in functional neuroimaging by Canadian research ethics boards |
| Q36258620 | Risk in emergency research using a waiver of/exception from consent: implications of a structured approach for institutional review board review |
| Q58663233 | The European Union Directive and the protection of incapacitated subjects in research: an ethical analysis |
| Q53832673 | The Inappropriate Use of Risk-Benefit Analysis in the Risk Assessment of Experimental Trauma-Focused Research. |
| Q92161408 | The Role of Inclusion Benefits in Ethics Committee Assessment of Research Studies |
| Q38863224 | The Role of Intuition in Risk/Benefit Decision-Making in Human Subjects Research |
| Q42697883 | The child's perspective on discomfort during medical research procedures: a descriptive study |
| Q47141658 | The development of the DISCO-RC for measuring children's discomfort during research procedures |
| Q24805632 | The ethical analysis of risk in intensive care unit research |
| Q34240740 | The risk-benefit task of research ethics committees: an evaluation of current approaches and the need to incorporate decision studies methods |
| Q48068911 | The role of research ethics committees in making decisions about risk |
| Q21994572 | Toward ethical norms and institutions for climate engineering research |
| Q49287946 | When are research risks reasonable in relation to anticipated benefits? |
| Q35939039 | Will ethical requirements bring critical care research to a halt? |
Search more.